|
16 May 2022 7:24 PM GMT Sign in |
Fund administration in real time. Data refreshed . |
![]() ![]() ![]() |
Portfolio of all Participating Organizations | ||
|
|
|
Portfolio of all Contributors/Partners | ||
|
|
|
Portfolio of all Funds/Joint Programmes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Funds & Joint Programmes Funds by Category Completed & Closed Funds | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Factsheet Bookmarks |
Project ID: | 00098865 | Description: | MCA03 #54 GIN VACCINATION COHO |
Fund: | Start Date *: | 23 Feb 2016 | |
Theme: | SO2 TREAT the infected |
End Date*: | 30 Jun 2016 |
Country: | Guinea | Project Status: | Financially Closed |
Participating Organization: | WHO - World Health Organization |
About
This study is designed to test the effectiveness of a vaccination program in preventing the transmission of Ebola from survivors to close contacts. It will determine the effect of natural seropositivity on the immunogenicity and safety of the VSV-ZEBOV vaccine. The funding from MPTF would be provided as an initial payment to enable the study to begin while additional funds are confirmed from other sources. Recent Documents
|
Key Figures
Report by
Financials
Latest Vouchers
Contacts
If you have questions about this programme you may wish to contact the RC office in Guinea or the lead agency for the programme. The MPTF Office Portfolio Manager (or Country Director with Delegation of Authority) for this programme:
|